The Ever-Expanding Association Between Rheumatologic Diseases and Tuberculosis

American Journal of Medicine

Volumn 119, Issue 6, 2006, Pages 470-477

  Franco Paredes, Carlos ^a   Díaz Borjon, Alejandro ^b   Senger, Mark A ^a   Barragan, Lorena ^c   Leonard, Michael ^a  

^a Division of Infectious Diseases   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Mycobacterium tuberculosis; Rheumatoid arthritis; Rheumatologic diseases; Spondylitis

Indexed keywords

ADALIMUMAB; ANTIMYCOBACTERIAL AGENT; BCG VACCINE; CORTICOSTEROID; ETANERCEPT; ETHAMBUTOL; FLUCONAZOLE; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; ISONIAZID; MACROLIDE; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFABUTIN; RIFAMPICIN; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ACHILLES TENDON; APHTHOUS STOMATITIS; ARTHRALGIA; ARTHRITIS; ARTHROPATHY; AUTOIMMUNE HEMOLYTIC ANEMIA; BACTERIAL ARTHRITIS; BCG VACCINATION; BLADDER CARCINOMA; CENTRAL NERVOUS SYSTEM DISEASE; CHONDROPATHY; CLINICAL FEATURE; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; ERYTHEMA NODOSUM; FEVER; FLU LIKE SYNDROME; GOUT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERURICEMIA; HYPOTENSION; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; INJECTION SITE ABSCESS; INJECTION SITE INFLAMMATION; JOINT SWELLING; LUPUS LIKE SYNDROME; LYMPHADENITIS; MUSCULOSKELETAL DISEASE; MUSCULOSKELETAL SYSTEM; MYCOBACTERIUM TUBERCULOSIS; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; OSTEITIS; OSTEOMYELITIS; PERICARDITIS; POLYARTHRITIS; PRIORITY JOURNAL; PSOAS ABSCESS; REACTIVE ARTHRITIS; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SYMPTOM; SYSTEMIC LUPUS ERYTHEMATOSUS; TENDINITIS; TENDON DISEASE; TENDON INJURY; TENDON RUPTURE; TENOSYNOVITIS; THROMBOCYTOPENIA; TUBERCULOSIS; TUBERCULOUS LYMPHADENITIS; TUBERCULOUS MENINGITIS; TUBERCULOUS OSTEOMYELITIS; TUBERCULOUS PERITONITIS; TUBERCULOUS SPONDYLITIS; UVEITIS; VACCINATION REACTION;

ANTITUBERCULAR AGENTS; ARTHRITIS, INFECTIOUS; BCG VACCINE; ERYTHEMA NODOSUM; HUMANS; LUPUS; OSTEOMYELITIS; RHEUMATIC DISEASES; SPONDYLITIS; TENOSYNOVITIS; TUBERCULOSIS; TUBERCULOSIS, PULMONARY;

EID: 33646905661     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2005.10.063     Document Type: Review

References (81)

1. Rothschild B.M., Martin L.D., Bercovier H., et al. Mycobacterium tuberculosis complex DNA from an extinct bison dated 17,000 years before the present. Clin Infect Dis 33 (2001) 305-311
2. Santos A.L., and Roberts C.A. A picture of tuberculosis in young Portuguese people in the early 20th century. a multidisciplinary study of the skeletal and historical evidence. Am J Phys Anthropol 115 (2001) 38-49
3. Fanning A. Tuberculosis 6. extrapulmonary disease. CMAJ 160 11 (1999) 1597-1603
4. Hopewell P.C. A clinical view of tuberculosis. Radiol Clin North Am 33 5 (1995) 641-653
5. Yao D.C., David J., and Sartoris D.J. Musculoskeletal tuberculosis. Radiol Clin North Am 33 5 (1995) 679-689
6. Weaver P., and Lifeso R. The radiological diagnosis of tuberculosis of the adult spine. Skeletal Radiol 12 (1984) 176-186
7. Gorse G.J., Pais M.J., Kusske J.A., and Cesario T.C. Tuberculous spondylitis. a report of six cases and a review of the literature. Medicine (Baltimore) 62 (1983) 178-193
8. Kramer N., and Rosenstein E.D. Rheumatologic manifestations of tuberculosis. Bull Rheum Dis 46 3 (1997) 5-8
9. Southwood T., and Gaston J.S.H. The molecular basis of Poncet's disease?. Br J Rheumatol 29 (1990) 491
10. Chowdhary V., Aggarwal A., and Misra R. Multifocal tuberculous dactylitis in an adult. J Clin Rheumatol 8 1 (2001) 35-37
11. El-Hennawy A.S., Goldstein M., and Nicastri A. Renal amyloidosis secondary to tuberculosis of cecum. Nephron 92 3 (2002) 708-710
12. Khaliq Y., and Zhanel G.G. Fluoroquinolone-associated tendinopathy. a critical review of the literature. Clin Infect Dis 36 (2003) 1404-1410
13. Lipsky B.A., and Baker C.A. Fluoroquinolone toxicity profiles. a review focusing on newer agents. Clin Infect Dis 28 (1999) 352-364
14. Siegal F.P., Eilbott D., Burger H., et al. Dose-limiting toxicity of rifabutin in AIDS-related complex. syndrome of arthralgia/arthritis. AIDS 4 5 (1990) 433-441
15. Berning S.E., and Iseman M. Rifamycin-induced lupus syndrome. Lancet 349 (1997) 1521-1522
16. Fritzler M.J. Drugs recently associated with lupus syndromes. Lupus 3 (1994) 455
17. Shakoor N., Michalska M., Harris C.A., and Block J.A. Drug-induced systemic lupus erythematosus associated with etanercept therapy. Lancet 359 (2002) 579-580
18. Hess E. Drug-induced lupus. N Engl J Med 318 (1988) 1460-1462
19. Scott J.T. Drug induced gout. Baillieres Clin Rheumatol 5 1 (1991) 39-60
20. Sanchez-Albisua I., Vidal M.L., Joya-Verde G., del Castillo F., de Jose M.I., and Garcia-Hortelano J. Tolerance of pyrazinamide in short course chemotherapy for pulmonary tuberculosis in children. Pediatr Infect Dis J 16 8 (1997) 760-763
21. Dorman S.E., Hatem C.L., and Tyagi S. Susceptibility to tuberculosis. clues from studies with inbred and outbred New Zealand white rabbits. Infect Immun 72 3 (2004) 1700-1705
22. Olsen N.J., and Stein M.C. New drugs for rheumatoid arthritis. N Engl J Med 350 21 (2004) 2167-2179
23. Bouza E., Garcia-Lechuz Moya J., and Munoz P. Infection in systemic lupus erythematosus and rheumatoid arthritis. Infect Dis Clin North Am 15 2 (2001) 1-30
24. Greenberg S.J. Infections in the immunocompromised rheumatologic patient. Crit Care Clin 18 (2002) 931-956
25. Hernandez Cruz B., Sifuentes Osornio J., Ponce de Leon Rosales S., et al. Mycobacterium tuberculosis infection in patients with systemic rheumatic diseases. A case-series. Clin Exp Rheumatol 17 (1999) 289
26. Victorio-Navarra S.T., Arroyo C.G., and Torralba T.P. Tuberculosis among Filipino patients with systemic lupus erythematosus. Lupus 4 S2 (1995) 89
27. Feng P.H., and Tan T.H. Tuberculosis in patients with systemic lupus erythematosus. Ann Rheum Dis 41 (1982) 11-14
28. Shyam C., and Malaviya A.N. Infection-related morbidity in systemic lupus erythematosus. a clinico-epidemiological study from northern India. Rheumatol Int 16 (1996) 1
29. Gomez-Reino J.J., Carmona L., Rodriguez-Valverde V., et al. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk. Arthritis Rheum 48 8 (2003) 2122-2127
30. Keane J., Gershon S., Wise R.P., et al. Tuberculosis associated with infliximab, a tumor necrosis factor α-neutralizing agent. N Engl J Med 345 15 (2001) 1098-1103
31. Brieber J., and Kavanaugh A. Consideration of the risk and treatment of tuberculosis in patients who have rheumatoid arthritis and receive biologic treatments. Rheum Dis Clin North Am 30 (2004) 257-270
32. Cush J.J. Safety overview of new disease-modifying antirheumatic drugs. Rheum Dis Clin North Am 30 (2004) 237-255
33. Wolfe F., Michaud K., Anderson J., and Urbansky K. Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy. Arthritis Rheum 50 2 (2004) 372-379
34. Mohan A.K., Cote T.R., Block J.A., Manadan A.M., Siegel J.N., and Braun M.M. Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor. Clin Infect Dis 39 (2004) 295-298
35. Keane J. Tumor necrosis factor blockers and reactivation of latent tuberculosis. Clin Infect Dis 39 (2004) 300-302
36. Garcia Vidal C., Rodriguez Fernandez S., Lacasa Martinez J., et al. Paradoxical response to antituberculous therapy in infliximab-treated patients with disseminated tuberculosis. Clin Infect Dis 40 (2005) 756-759
37. Gardman M.A., Keystone E.C., Menzies R., et al. Anti-tumor necrosis factor agents and tuberculosis risk. mechanisms of action and clinical management. Lancet Infect Dis 3 (2003) 148-155
38. Keystone E., and Haraoui B. Adalimumab therapy in rheumatoid arthritis. Rheum Dis Clin North Am 30 (2004) 349-364
39. Long R., and Gardam M. Tumour necrosis factor-α inhibitors and the reactivation of latent tuberculosis infection. CMAJ 168 9 (2003)
40. Franco-Paredes C., and Agudelo C. The Ever Expanding Clinical Spectrum of Tuberculosis. J Clin Rheumatol 8 1 (2002) 1-2
41. Alvarez S., and McCabe W. Extrapulmonary tuberculosis revisited. a review of experience at Boston City and other hospitals. Medicine (Baltimore) 63 1 (1984) 25-55
42. Rieder H., Snider D., and Cauthen G.M. Extrapulmonary tuberculosis in the United States. Am Rev Respir Dis 141 (1990) 347-351
43. Shafer R.W., Kim D.S., Weiss J., and Quale J.M. Extrapulmonary tuberculosis in patients with human immunodeficiency virus infection. Medicine (Baltimore) 79 6 (1991) 384-397
44. Havlir D., and Barnes P. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 340 5 (1999) 367-373
45. Hunt D. Problems in diagnosing osteoarticular tuberculosis. JAMA 190 (1964) 95-98
46. Mehta J.B., Dutt A., Harvill L., and Mathews K.M. Epidemiology of extra pulmonary tuberculosis. A comparative analysis with pre-AIDS era. Chest 99 (1991) 1134-1138
47. Lifeso R., Weaver P., and Harder E. Tuberculous spondylitis in adults. J Bone Joint Surg. Am 67 (1985) 1405-1413
48. Centers for Disease Control and Prevention. Treatment of tuberculosis. MMWR Morb Mortal Wkly Rep 52 (2003) 1-77
49. Walker G. Failure of early recognition of skeletal tuberculosis. BMJ 1 (1968) 682-683
50. Versfeld G., and Solomon A. A diagnostic approach to tuberculosis of bones and joints. J Bone Joint Surg Br 64 (1982) 446-449
51. Kim Y.H. Total knee arthroplasty for tuberculous arthritis. J Bone Joint Surg 70 (1988) 1322-1330
52. Rasool M., Govender S., and Naidoo K. Cystic tuberculosis of bone in children. J Bone Joint Surg Br 76 (1994) 113-117
53. Evans C.A.W., Jellis J., Hughes S.P.F., Remick D.G., and Friedland J.S. Tumor necrosis factor-α, interleukin-6, and interleukin-8 secretion and the acute-phase response in patients with bacterial and tuberculous osteomyelitis. J Infect Dis 177 (1998) 1582-1587
54. Garrido G., Gomez-Reino J.J., Fernandez-Dapica P., et al. A review of peripheral tuberculous arthritis. Semin Arthritis Rheum 18 (1988) 142-149
55. Puttick M.P.E., Stein H.B., Chan R.T., Elwood R., How A.R., and Reid G.D. Soft tissue tuberculosis. a series of 11 cases. J Rheumatol 22 (1995) 1321-1325
56. Belzunegui J., Plazaola I., Uriarte E., et al. Primary tuberculosis muscle abscess in a patient with systemic lupus erythematosus. Br J Rheumatol 34 (1995) 1177-1178
57. Harrigan R.A., Kauffman F.H., and Love M.B. Tuberculosis psoas abscess. J Emerg Med 13 4 (1995) 493-498
58. Huang D.Y. Tuberculosis muscle abscess. an unusual presentation of tuberculosis. Am J Med 88 (1990) 57-59
59. Franco-Paredes C., and Blumberg H. Tuberculosis psoas abscess caused by Mycobacterium tuberculosis and Staphylococcus aureus. case report and review. Am J Med Sci 321 6 (2001) 415-417
60. Wook Moon J., Chang Y.S., Kim S.K., et al. The clinical utility of polymerase chain reaction for the diagnosis of pleural tuberculosis. Clin Infect Dis 41 (2005) 660-666
61. Kearns A.M., Fremman R., Steward M., et al. A rapid polymerase chain reaction technique for detecting Mycobacterium tuberculosis in a variety of clinical specimens. J Clin Pathol 51 (1998) 922-924
62. Cheng V.C.C., Yam W.C., Hung I.F.N., et al. Clinical evaluation of the polymerase chain reaction for the rapid diagnosis of tuberculosis. J Clin Pathol 57 (2004) 281-285
63. Centers for Disease Control and Prevention. Uveitis associated with rifabutin therapy. MMWR Morb Mortal Wkly Rep 43 (1994) 658
64. Yew W.W., Chan C.K., Cau C.H., et al. Outcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin/levofloxacin containing regimens. Chest 117 (2000) 744-751
65. Bozeman L., Burman L., Metchock B., et al. Fluoroquinolone susceptibility among Mycobacterium tuberculosis isolates from the United States and Canada. Clin Infect Dis 40 (2005) 386-391
66. Blumberg H.M., Burman W.J., Chaisson R.E., et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America. treatment of tuberculosis. Am J Respir Crit Care Med 169 2 (2004) 316-317
67. Dall L., Long L., and Standford J. Poncet's disease. tuberculous rheumatism. Rev Infect Dis 11 (1989) 105-107
68. Cho K.H., Lee D., Chun H.S., et al. Erythema induratum with pulmonary tuberculosis. report of three cases. J Dermatol 22 (1995) 143-148
69. Gaston J.S.H., Life P.F., Jenner P.J., et al. Recognition of a Mycobacteria-specific epitope in the 65-kD heat-shock protein by synovial fluid derived T cell clones. J Exp Med 171 (1990) 831-841
70. Maini R. Infliximab treatment of rheumatoid arthritis. Rheum Dis Clin North Am 30 (2004) 329-347
71. Centers for Disease Control and Prevention. Tuberculosis associated with blocking agents against tumor necrosis factor-alpha-California, 2002-2003. MMWR Morb Mortal Wkly Rep 53 30 (2004) 683-686
72. Lotte A., Wasz-Höckert P., Poisson N., Dumitrescu N., Verron N., and Couvet E. BCG complications. Adv Tuberc Res 21 (1984) 107-193
73. World Health Organization. Issues Relating to the Use of BCG in Immunization Programmes (1999), WHO
74. Poliyel J.M., Hughes A., Chiswick M., et al. Adverse local reactions from accidental BCG overdose in infants. BMJ 313 (1996) 528-529
75. Turnbull F.M., McIntyre P.B., Achat H.M., et al. National study of adverse reactions alter vaccination with bacille Calmette-Guerin. Clin Infect Dis 34 (2002) 447-453
76. Jun-Ichiro N., Kamenosono A., Kirshna Pada S., Shinji Y., Junko I., and Yukihisa M. Bacille Calmette-Guérin osteomyelitis. Pediatr Infect Dis J 16 3 (1997) 332-333
77. Kröger L., Korppi M., Brander E., et al. Osteitis caused by bacille Calmette-Guérin vaccination. a retrospective analysis of 222 cases. J Infect Dis 172 (1995) 574-576
78. Civen R., Berlin G., and Panosian C. Vertebral osteomyelitis after intravesical administration of Bacille Calmette-Guerin. Clin Infect Dis 18 (1994) 1013-1014
79. Hakim S., Heaney J.A., Heinz T., and Zwolak R.W. Psoas abscess following intravesical bacillus Calmette-Guérin for bladder cancer. a case report. J Urol 150 (1993) 188-189
80. Pancaldi P., Van Linthoudt D., Alborino S., et al. Reiter's syndrome after intravesical bacillus Calmette-Guerin treatment for superficial bladder carcinoma. Br J Rheumatol 32 (1993) 1096-1098
81. Hughes R.A., Allard S.A., and Main R.N. Arthritis associated with adjuvant mycobacterial treatment for carcinoma of the bladder. Ann Rheum Dis 48 (1989) 432-434